MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - pharmaceuticals
- ALEMBIC LTD - ADCOCK INGRAM (S. Africa)
ALEMBIC LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results
ALEMBIC LTD Change
Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More
ADCOCK INGRAM (S. Africa)
Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
Financials
 ALEMBIC LTD  ADCOCK INGRAM |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| ALEMBIC LTD Mar-18 |
ADCOCK INGRAM Jun-14 |
ALEMBIC LTD/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 72 | 360 | - | |
| Low | Rs | 34 | 260 | - | |
| Sales per share (Unadj.) | Rs | 4.7 | 107.2 | - | |
| Earnings per share (Unadj.) | Rs | 6.1 | -27.0 | - | |
| Cash flow per share (Unadj.) | Rs | 6.2 | -22.4 | - | |
| Dividends per share (Unadj.) | Rs | 0.20 | 0 | - | |
| Dividend yield (eoy) | % | 0.4 | 0 | - | |
| Book value per share (Unadj.) | Rs | 40.7 | 84.1 | - | |
| Shares outstanding (eoy) | m | 267.03 | 168.78 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 11.3 | 2.9 | 389.3% | |
| Avg P/E ratio | x | 8.7 | -11.5 | -75.6% | |
| P/CF ratio (eoy) | x | 8.5 | -13.9 | -61.2% | |
| Price / Book Value ratio | x | 1.3 | 3.7 | 35.3% | |
| Dividend payout | % | 3.3 | 0 | - | |
| Avg Mkt Cap | Rs m | 14,139 | 52,343 | 27.0% | |
| No. of employees | `000 | NA | 4.3 | 0.0% | |
| Total wages/salary | Rs m | 207 | 3,285 | 6.3% | |
| Avg. sales/employee | Rs Th | NM | 4,214.0 | - | |
| Avg. wages/employee | Rs Th | NM | 765.2 | - | |
| Avg. net profit/employee | Rs Th | NM | -1,061.8 | - | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 1,255 | 18,091 | 6.9% | |
| Other income | Rs m | 370 | 127 | 292.2% | |
| Total revenues | Rs m | 1,625 | 18,217 | 8.9% | |
| Gross profit | Rs m | 111 | -3,135 | -3.5% | |
| Depreciation | Rs m | 38 | 781 | 4.8% | |
| Interest | Rs m | 2 | 490 | 0.3% | |
| Profit before tax | Rs m | 442 | -4,279 | -10.3% | |
| Minority Interest | Rs m | 0 | -12 | 0.0% | |
| Prior Period Items | Rs m | 1,212 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 24 | 267 | 9.0% | |
| Profit after tax | Rs m | 1,630 | -4,558 | -35.8% | |
| Gross profit margin | % | 8.9 | -17.3 | -51.1% | |
| Effective tax rate | % | 5.4 | -6.2 | -86.8% | |
| Net profit margin | % | 129.8 | -25.2 | -515.3% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 1,867 | 13,250 | 14.1% | |
| Current liabilities | Rs m | 591 | 7,455 | 7.9% | |
| Net working cap to sales | % | 101.6 | 32.0 | 317.3% | |
| Current ratio | x | 3.2 | 1.8 | 177.7% | |
| Inventory Days | Days | 94 | 111 | 85.0% | |
| Debtors Days | Days | 74 | 124 | 59.3% | |
| Net fixed assets | Rs m | 1,791 | 7,723 | 23.2% | |
| Share capital | Rs m | 534 | 84 | 635.9% | |
| Net worth | Rs m | 10,858 | 14,199 | 76.5% | |
| Long term debt | Rs m | 41 | 4,990 | 0.8% | |
| Total assets | Rs m | 11,591 | 26,824 | 43.2% | |
| Interest coverage | x | 260.9 | -7.7 | -3,374.0% | |
| Debt to equity ratio | x | 0 | 0.4 | 1.1% | |
| Sales to assets ratio | x | 0.1 | 0.7 | 16.1% | |
| Return on assets | % | 14.1 | -15.2 | -92.8% | |
| Return on equity | % | 15.0 | -32.1 | -46.8% | |
| Return on capital | % | 15.2 | -19.8 | -76.7% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 236 | 1,544 | 15.3% | |
| From Investments | Rs m | -224 | -474 | 47.2% | |
| From Financial Activity | Rs m | -27 | 4,529 | -0.6% | |
| Net Cashflow | Rs m | -15 | 5,599 | -0.3% | |
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.97 Rs / ZAR
Compare ALEMBIC LTD With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare ALEMBIC LTD With: AJANTA PHARMA SUVEN LIFESCIENCES ORCHID PHARMA LTD VENUS REMEDIES BIOCON
| Advertisement |
| Last 2 Days to Claim Free 12-Month Access to Double Income |
| For our valued subscribers only - act by 11:59pm, 28th January - and claim free 12-month access to Rahul Shah's Double Income. Double Income is a way for subscribers like you to potentially double your monthly income in the long run. Click here for details. |
Today's Market
Indian Indices Witness Huge Selling; Sensex Ends 458 Points Lower(Closing)
After opening on a negative note in the morning trade today, India share markets witnessed further selling and ended their session deep in the red.
Related Views On News
ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)
Aug 27, 2019 | Updated on Aug 27, 2019For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.
ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)
May 17, 2019 | Updated on May 17, 2019For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.
Aster DM Healthcare (IPO)
Feb 10, 2018Should you subscribe to the IPO of Aster DM Healthcare Ltd?
More Views on NewsMost Popular
Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)
Jan 14, 2020The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.
Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)
Jan 15, 2020These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.
How to Buy the Best Safe Stocks in 2020 (The 5 Minute Wrapup)
Jan 17, 2020Don't fall for the safe stocks narrative going around in the stock market these days.
For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)
Jan 17, 2020This is how the biggest trading profits are made.
What the Infosys Results Tell Us About the Next Infosys (The 5 Minute Wrapup)
Jan 15, 2020If you're interested in the next Infosys, I'll tell you where to look.
More